Vestmark Advisory Solutions Inc. lifted its holdings in Relx Plc (NYSE:RELX – Get Rating) by 7.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 64,083 shares of the technology company’s stock after purchasing an additional 4,290 shares during the quarter. Vestmark Advisory Solutions Inc.’s holdings in Relx were worth $1,776,000 as of its most recent SEC filing.
A number of other institutional investors have also recently made changes to their positions in the business. Eagle Ridge Investment Management increased its stake in shares of Relx by 1.6% in the 4th quarter. Eagle Ridge Investment Management now owns 298,624 shares of the technology company’s stock valued at $8,278,000 after purchasing an additional 4,666 shares in the last quarter. Ritholtz Wealth Management increased its stake in shares of Relx by 338.1% in the 4th quarter. Ritholtz Wealth Management now owns 108,306 shares of the technology company’s stock valued at $3,002,000 after purchasing an additional 83,583 shares in the last quarter. Ronald Blue Trust Inc. increased its stake in shares of Relx by 59.9% in the 4th quarter. Ronald Blue Trust Inc. now owns 5,176 shares of the technology company’s stock valued at $126,000 after purchasing an additional 1,939 shares in the last quarter. Gallacher Capital Management LLC purchased a new position in shares of Relx in the 4th quarter valued at about $302,000. Finally, London & Capital Asset Management Ltd increased its stake in Relx by 8.2% during the 3rd quarter. London & Capital Asset Management Ltd now owns 41,741 shares of the technology company’s stock worth $1,015,000 after buying an additional 3,155 shares in the last quarter. Institutional investors and hedge funds own 3.41% of the company’s stock.
Analyst Ratings Changes
RELX has been the subject of several research reports. Barclays lowered Relx from an “overweight” rating to an “equal weight” rating in a research note on Tuesday, January 31st. StockNews.com initiated coverage on Relx in a report on Thursday, March 16th. They set a “hold” rating on the stock. Morgan Stanley lowered their target price on Relx from GBX 3,020 ($37.11) to GBX 2,950 ($36.25) in a report on Friday, December 16th. Credit Suisse Group boosted their target price on Relx from GBX 2,800 ($34.40) to GBX 2,860 ($35.14) in a report on Friday, February 17th. Finally, JPMorgan Chase & Co. boosted their target price on Relx from GBX 2,810 ($34.53) to GBX 2,840 ($34.89) in a report on Wednesday, March 15th.
Relx Trading Up 0.4 %
Relx Increases Dividend
The business also recently disclosed a Semi-Annual dividend, which will be paid on Monday, June 12th. Shareholders of record on Friday, April 28th will be paid a $0.466 dividend. The ex-dividend date is Thursday, April 27th. This is an increase from Relx’s previous Semi-Annual dividend of $0.44.
Relx Company Profile
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Read More
- Get a free copy of the StockNews.com research report on Relx (RELX)
- MarketBeat Week in Review – 3/27 – 3/31
- What is a Gold IRA, and is it a Viable Investment?
- Is Braze, Inc Ready To Rocket Higher?
- Mullen Automotive Makes Deliveries; Short-Squeeze Possible
- Can Frontline Maintain This Momentum?
Want to see what other hedge funds are holding RELX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Relx Plc (NYSE:RELX – Get Rating).
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.